For patients presenting with colonic polyps and progressing via the sCRC pathway, the detection of dysplastic tissue could also be aided by the addition of caspase-4 to current histopathological assessment, allowing earlier detection of high-risk individuals. This evidence concerns the gene CASP4 and colon inflammatory polyp.